References
- Gurgueira G, Carvalho WB. Inhaled nitric oxide: clinical application. J Pneumol. 2003;29(5):325–31.
- Grifiths MJD, Mcauley DF, Perkins GD, Barrett N, Blackwood B, Boyle A, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Resp Res. 2019;(6:e000420).
- Care I, Papazian L, Aubron C, Brochard L, Chiche JD, Combes A, et al. Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care [Internet]. 2019;(9:69).
- Chen L, Liu P, Gao H, Sun B, Chao D, Wang F, et al. Inhalation of Nitric Oxide in the Treatment of Severe Acute Respiratory Syndrome : A Rescue Trial in Beijing. Clin Infect Dis. 2004;39:1531–5.
- Keyaerts E, Vijgen L, Chen L, Maes P, Hedenstierna G, Ranst M Van. Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine , a nitric oxide donor compound. Int J Infec Dis. 2004;(8):223–6.
- Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign : Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Vol. 2019. 2020. 1–32 p.
- Covid- S, Martinez FJ. Severe Covid-19. NEJM. 2020;1–10.
- Kobayashi J, Murata I. Nitric oxide inhalation as an interventional rescue therapy for COVID ‑ 19 ‑ induced acute respiratory distress syndrome. Ann Intensive Care [Internet]. 2020;(10:61):9–10.